Therapeutic drug monitoring of biologics in inflammatory bowel disease: an evidence-based multidisciplinary guideline
- MeSH Terms
Inflammatory bowel diseases;
Therapeutic drug monitoring;
Biologics;- Guideline Contact
- Yu Zhang, whxhzy@163.com
- Keywords
- Inflammatory bowel diseases; Therapeutic drug monitoring; Biologics; Evidence-based multidisciplinary guideline
- Date for Review
- 01/10/2024
- Expected Publication Date
- 01/01/2025
- Date of Last Evidence Search
- 15/12/2023
- Methods Applied
- Systematic review; Evidence synthesis; GRADE assessment of quality of evidence; GRADE evidence to decision framework; GRADE adolopment;
- Publication Scope
- Individualized therapy in biologics of inflammatory bowel disease
- Countries of Application
- Asia-Pacific countries
- Guideline Publication Status
- Development
- Languages
- English
- Willingness to Collaborate
- Yes
- Name of Endorsing Organization
- Chinese Pharmaceutical Association Hospital Pharmacy Professional Committee, Inflammatory Bowel Disease Group, Chinese Society of Gastroenterology, Chinese Medical Association, Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society, Chin